. Author manuscript; available in PMC: 2024 Apr 1.

Published in final edited form as: J Am Acad Dermatol. 2023 Jan 20;88(4):841–847. doi: 10.1016/j.jaad.2023.01.014

Table 3 –

One-year incidence of inflammatory bowel among patients with acne treated with oral tetracycline-class antibiotics

	Acne			Oral tetracycline-class antibiotic			Odds Ratio	95% CI
	Patients, total, n	Patients with incident outcome, n	IR/1000	Patients, total, n	Patients with incident outcome, n	IR/1000	Odds Ratio	95% CI
Outcomes
Any inflammatory bowel disease	144,711	191	1.32	144,986	191	1.32	1.00	0.82–1.22
Crohn’s disease	145,264	130	0.89	145,436	142	0.98	1.09	0.86–1.38
Ulcerative colitis	145,602	142	0.98	145,723	111	0.76	0.78	0.61–1.00